Edition:
United States

Viking Therapeutics Inc (VKTX.OQ)

VKTX.OQ on NASDAQ Stock Exchange Capital Market

10.31USD
4:00pm EDT
Change (% chg)

$0.31 (+3.10%)
Prev Close
$10.00
Open
$10.07
Day's High
$10.39
Day's Low
$9.95
Volume
356,001
Avg. Vol
554,211
52-wk High
$13.40
52-wk Low
$0.88

Latest Key Developments (Source: Significant Developments)

Viking Therapeutics Files For Mixed Shelf Of Up To $450 Mln
Wednesday, 11 Jul 2018 05:44pm EDT 

July 11 (Reuters) - Viking Therapeutics Inc ::VIKING THERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO $450 MILLION – SEC FILING.  Full Article

Viking Therapeutics Completes Enrollment In Phase 2 Study Of VK2809
Tuesday, 5 Jun 2018 07:01am EDT 

June 5 (Reuters) - Viking Therapeutics Inc ::VIKING THERAPEUTICS COMPLETES ENROLLMENT IN PHASE 2 STUDY OF VK2809 IN PATIENTS WITH HYPERCHOLESTEROLEMIA AND NON-ALCOHOLIC FATTY LIVER DISEASE.VIKING THERAPEUTICS INC - TOP-LINE RESULTS EXPECTED IN SECOND HALF OF 2018.VIKING THERAPEUTICS INC - TRIAL'S PRIMARY ENDPOINT WILL EVALUATE EFFECT OF VK2809 TREATMENT ON LDL-C AFTER 12 WEEKS COMPARED TO PLACEBO.  Full Article

Viking Therapeutics - Pricing Public Offering Of 11 Mln Shares At $5 Per Share
Friday, 2 Feb 2018 08:33am EST 

Feb 2 (Reuters) - Viking Therapeutics Inc ::VIKING THERAPEUTICS ANNOUNCES PRICING OF $55.0 MILLION PUBLIC OFFERING OF COMMON STOCK.VIKING THERAPEUTICS INC - PRICING OF ITS PUBLIC OFFERING OF 11 MILLION SHARES OF ITS COMMON STOCK AT A PRICE TO PUBLIC OF $5.00 PER SHARE.  Full Article

Viking Therapeutics Announces Proposed Public Offering Of Common Stock
Thursday, 1 Feb 2018 04:01pm EST 

Feb 1 (Reuters) - Viking Therapeutics Inc ::VIKING THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.VIKING THERAPEUTICS - INTENDS TO OFFER AND SELL, SHARES OF ITS COMMON STOCK IN AN UNDERWRITTEN PUBLIC OFFERING.VIKING THERAPEUTICS INC - INTENDS TO USE NET PROCEEDS FROM OFFERING FOR CONTINUED DEVELOPMENT OF ITS VK5211, VK2809 AND VK0214 PROGRAMS.  Full Article

Viking Therapeutics says Resale By Selling Stockholders Of Up To 2.6 Mln Shares
Wednesday, 20 Dec 2017 05:35pm EST 

Dec 20 (Reuters) - Viking Therapeutics Inc ::VIKING THERAPEUTICS - RESALE BY SELLING STOCKHOLDERS OF UP TO 2.6 MILLION SHARES OF CO'S COMMON STOCK - SEC FILING.  Full Article

Sphera Funds Management Ltd Reports 7.43 Pct Passive Stake In Viking Therapeutics
Monday, 18 Dec 2017 09:59am EST 

Dec 18 (Reuters) - Viking Therapeutics Inc ::SPHERA FUNDS MANAGEMENT LTD REPORTS 7.43 PERCENT PASSIVE STAKE IN VIKING THERAPEUTICS INC AS OF DECEMBER 7 - SEC FILING.  Full Article

Viking Therapeutics Announces Closing Of Public Offering
Monday, 11 Dec 2017 04:15pm EST 

Dec 11 (Reuters) - Viking Therapeutics Inc ::VIKING THERAPEUTICS ANNOUNCES CLOSING OF PUBLIC OFFERING OF COMMON STOCK.  Full Article

Viking Therapeutics Announces Pricing Of $12.8 Million Public Offering Of Common Stock
Wednesday, 6 Dec 2017 08:09pm EST 

Dec 6 (Reuters) - Viking Therapeutics Inc ::VIKING THERAPEUTICS ANNOUNCES PRICING OF $12.8 MILLION PUBLIC OFFERING OF COMMON STOCK.VIKING THERAPEUTICS INC- ‍ANNOUNCED PRICING OF ITS PUBLIC OFFERING OF 5,130,435 SHARES OF ITS COMMON STOCK AT A PRICE TO PUBLIC OF $2.50 PER SHARE​.  Full Article

Viking Therapeutics Announces Proposed Public Offering Of Common Stock
Tuesday, 5 Dec 2017 04:18pm EST 

Dec 5 (Reuters) - Viking Therapeutics Inc ::VIKING THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.VIKING THERAPEUTICS - INTENDS TO USE NET PROCEEDS FROM STOCK OFFERING FOR CONTINUED DEVELOPMENT OF ITS VK5211, VK2809 AND VK0214 PROGRAMS.  Full Article

Viking Therapeutics reports third quarter 2017 financial results
Wednesday, 8 Nov 2017 04:05pm EST 

Nov 8 (Reuters) - Viking Therapeutics Inc :Viking Therapeutics reports third quarter 2017 financial results and provides corporate update.Q3 loss per share $0.22.Q3 earnings per share view $-0.20 -- Thomson Reuters I/B/E/S.  Full Article

BRIEF-Viking Therapeutics Q1 Loss Per Share $0.08

* VIKING THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE